{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:55:34Z","timestamp":1791665734920,"version":"4.3.4"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"8","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50-AG016574"],"award-info":[{"award-number":["P50-AG016574"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50-NS072187"],"award-info":[{"award-number":["P50-NS072187"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01-AG003949"],"award-info":[{"award-number":["P01-AG003949"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8,1]]},"DOI":"10.1093\/jnen\/nlx049","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T14:23:47Z","timestamp":1500042227000},"page":"676-682","source":"Crossref","is-referenced-by-count":61,"title":["Perry Syndrome: A Distinctive Type of TDP-43 Proteinopathy"],"prefix":"10.1093","volume":"76","author":[{"given":"Takayasu","family":"Mishima","sequence":"first","affiliation":[{"name":"From the Department of Neuroscience, Mayo Clinic, Jacksonville, Florida (TM, SK, W-LL, KK, MC-C, DWD); Department of Neurology, Fukuoka University, Fukuoka, Japan (TM, YT); Department of Neurology, Mayo Clinic, Jacksonville, Florida (ZKW); and Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama (SJO)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Koga","sequence":"additional","affiliation":[{"name":"From the Department of Neuroscience, Mayo Clinic, Jacksonville, Florida (TM, SK, W-LL, KK, MC-C, DWD); Department of Neurology, Fukuoka University, Fukuoka, Japan (TM, YT); Department of Neurology, Mayo Clinic, Jacksonville, Florida (ZKW); and Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama (SJO)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Lang","family":"Lin","sequence":"additional","affiliation":[{"name":"From the Department of Neuroscience, Mayo Clinic, Jacksonville, Florida (TM, SK, W-LL, KK, MC-C, DWD); Department of Neurology, Fukuoka University, Fukuoka, Japan (TM, YT); Department of Neurology, Mayo Clinic, Jacksonville, Florida (ZKW); and Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama (SJO)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kasanuki","sequence":"additional","affiliation":[{"name":"From the Department of Neuroscience, Mayo Clinic, Jacksonville, Florida (TM, SK, W-LL, KK, MC-C, DWD); Department of Neurology, Fukuoka University, Fukuoka, Japan (TM, YT); Department of Neurology, Mayo Clinic, Jacksonville, Florida (ZKW); and Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama (SJO)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Castanedes-Casey","sequence":"additional","affiliation":[{"name":"From the Department of Neuroscience, Mayo Clinic, Jacksonville, Florida (TM, SK, W-LL, KK, MC-C, DWD); Department of Neurology, Fukuoka University, Fukuoka, Japan (TM, YT); Department of Neurology, Mayo Clinic, Jacksonville, Florida (ZKW); and Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama (SJO)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew K.","family":"Wszolek","sequence":"additional","affiliation":[{"name":"From the Department of Neuroscience, Mayo Clinic, Jacksonville, Florida (TM, SK, W-LL, KK, MC-C, DWD); Department of Neurology, Fukuoka University, Fukuoka, Japan (TM, YT); Department of Neurology, Mayo Clinic, Jacksonville, Florida (ZKW); and Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama (SJO)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin J.","family":"Oh","sequence":"additional","affiliation":[{"name":"From the Department of Neuroscience, Mayo Clinic, Jacksonville, Florida (TM, SK, W-LL, KK, MC-C, DWD); Department of Neurology, Fukuoka University, Fukuoka, Japan (TM, YT); Department of Neurology, Mayo Clinic, Jacksonville, Florida (ZKW); and Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama (SJO)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Tsuboi","sequence":"additional","affiliation":[{"name":"From the Department of Neuroscience, Mayo Clinic, Jacksonville, Florida (TM, SK, W-LL, KK, MC-C, DWD); Department of Neurology, Fukuoka University, Fukuoka, Japan (TM, YT); Department of Neurology, Mayo Clinic, Jacksonville, Florida (ZKW); and Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama (SJO)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis W.","family":"Dickson","sequence":"additional","affiliation":[{"name":"From the Department of Neuroscience, Mayo Clinic, Jacksonville, Florida (TM, SK, W-LL, KK, MC-C, DWD); Department of Neurology, Fukuoka University, Fukuoka, Japan (TM, YT); Department of Neurology, Mayo Clinic, Jacksonville, Florida (ZKW); and Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama (SJO)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,7,14]]},"reference":[{"key":"key\n\t\t\t\t20180328174221_nlx049-B1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1001\/archneur.1975.00490440058009","article-title":"Hereditary mental depression and Parkinsonism with taurine deficiency","volume":"32","author":"Perry","year":"1975","journal-title":"Arch Neurol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B2","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1212\/WNL.38.4.637","article-title":"Familial parkinsonism, apathy, weight loss, and central hypoventilation: successful long-term management","volume":"38","author":"Roy","year":"1988","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B3","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1212\/WNL.40.12.1882","article-title":"Dominantly inherited apathy, central hypoventilation, and Parkinson\u2019s syndrome: clinical, biochemical, and neuropathologic studies of 2 new cases","volume":"40","author":"Perry","year":"1990","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B4","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/ana.410340614","article-title":"Familial parkinsonism with depression: a clinicopathological study","volume":"34","author":"Bhatia","year":"1993","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B5","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1212\/WNL.58.7.1025","article-title":"Japanese family with parkinsonism, depression, weight loss, and central hypoventilation","volume":"58","author":"Tsuboi","year":"2002","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.parkreldis.2008.07.005","article-title":"Pallidonigral TDP-43 pathology in Perry syndrome","volume":"15","author":"Wider","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/ng.293","article-title":"DCTN1 mutations in Perry syndrome","volume":"41","author":"Farrer","year":"2009","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B8","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.parkreldis.2014.05.004","article-title":"Three families with Perry syndrome from distinct parts of the world","volume":"20","author":"Tacik","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B9","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/NEN.0b013e3181baacec","article-title":"Transactivation response DNA-binding protein 43 microvasculopathy in frontotemporal degeneration and familial Lewy body disease","volume":"68","author":"Lin","year":"2009","journal-title":"J Neuropathol Exp Neurol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B10","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","article-title":"TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"351","author":"Arai","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B11","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ana.21154","article-title":"TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer\u2019s disease","volume":"61","author":"Amador-Ortiz","year":"2007","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00401-013-1211-9","article-title":"Staging TDP-43 pathology in Alzheimer\u2019s disease","volume":"127","author":"Josephs","year":"2014","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00401-008-0480-1","article-title":"Phosphorylated TDP-43 in Alzheimer\u2019s disease and dementia with Lewy bodies","volume":"117","author":"Arai","year":"2009","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00401-010-0681-2","article-title":"TDP-43 pathology in primary progressive aphasia and frontotemporal dementia with pathologic Alzheimer disease","volume":"120","author":"Bigio","year":"2010","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B16","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00401-011-0879-y","article-title":"TDP-43 pathological changes in early onset familial and sporadic Alzheimer\u2019s disease, late onset Alzheimer\u2019s disease and Down\u2019s syndrome: association with age, hippocampal sclerosis and clinical phenotype","volume":"122","author":"Davidson","year":"2011","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/NEN.0b013e31817713b5","article-title":"Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies","volume":"67","author":"Uryu","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B18","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/brain\/awr053","article-title":"Hippocampal sclerosis in advanced age: clinical and pathological features","volume":"134","author":"Nelson","year":"2011","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B19","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/ana.24388","article-title":"Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease","volume":"77","author":"Nag","year":"2015","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-007-0261-2","article-title":"Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases","volume":"114","author":"Nakashima-Yasuda","year":"2007","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00401-010-0702-1","article-title":"Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy","volume":"120","author":"Yokota","year":"2010","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00401-014-1358-z","article-title":"Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP type A","volume":"129","author":"Aoki","year":"2015","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00401-008-0463-2","article-title":"Accumulation of phosphorylated TDP-43 in brains of patients with argyrophilic grain disease","volume":"117","author":"Fujishiro","year":"2009","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00401-013-1110-0","article-title":"TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies","volume":"126","author":"Arnold","year":"2013","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B25","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00401-013-1087-8","article-title":"Corticobasal degeneration with olivopontocerebellar atrophy and TDP-43 pathology: an unusual clinicopathologic variant of CBD","volume":"125","author":"Kouri","year":"2013","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B26","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1093\/brain\/awv220","article-title":"TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes","volume":"138","author":"Tan","year":"2015","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00401-009-0547-7","article-title":"Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes","volume":"118","author":"Josephs","year":"2009","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/ng1123","article-title":"Mutant dynactin in motor neuron disease","volume":"33","author":"Puls","year":"2003","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B29","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/ana.20468","article-title":"Distal spinal and bulbar muscular atrophy caused by dynactin mutation","volume":"57","author":"Puls","year":"2005","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B30","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1212\/01.WNL.0000134608.83927.B1","article-title":"Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS","volume":"63","author":"Munch","year":"2004","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B31","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/ana.20631","article-title":"Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD","volume":"58","author":"Munch","year":"2005","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B32","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1001\/archneur.65.10.1326","article-title":"Development of a high-throughput microarray-based resequencing system for neurological disorders and its application to molecular genetics of amyotrophic lateral sclerosis","volume":"65","author":"Takahashi","year":"2008","journal-title":"Arch Neurol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B33","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1016\/j.neurobiolaging.2014.07.003","article-title":"Identify mutation in amyotrophic lateral sclerosis cases using HaloPlex target enrichment system","volume":"35","author":"Liu","year":"2014","journal-title":"Neurobiol Aging"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B34","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ana.24346","article-title":"Defining neurodegeneration on Guam by targeted genomic sequencing","volume":"77","author":"Steele","year":"2015","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B35","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ana.24306","article-title":"Amyotrophic lateral sclerosis onset is influenced by the burden of rare variants in known amyotrophic lateral sclerosis genes","volume":"77","author":"Cady","year":"2015","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B36","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1212\/WNL.0b013e3181a92c4c","article-title":"Characterization of DCTN1 genetic variability in neurodegeneration","volume":"72","author":"Vilarino-Guell","year":"2009","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B37","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s00415-014-7262-6","article-title":"Latin America\u2019s first case of Perry syndrome and a new treatment option for respiratory insufficiency","volume":"261","author":"Pretelt","year":"2014","journal-title":"J Neurol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B38","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/jnen\/nlw073","article-title":"Chronic traumatic encephalopathy pathology in multiple system atrophy","volume":"75","author":"Koga","year":"2016","journal-title":"J Neuropathol Exp Neurol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B39","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00401-015-1506-0","article-title":"SNTF immunostaining reveals previously undetected axonal pathology in traumatic brain injury","volume":"131","author":"Johnson","year":"2016","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B40","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jns.2011.10.006","article-title":"Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): a misdiagnosed disease entity","volume":"314","author":"Sundal","year":"2012","journal-title":"J Neurol Sci"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00401-008-0408-9","article-title":"Ultrastructural localization of TDP-43 in filamentous neuronal inclusions in various neurodegenerative diseases","volume":"116","author":"Lin","year":"2008","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00401-011-0845-8","article-title":"harmonized classification system for FTLD-TDP pathology","volume":"122","author":"Mackenzie","year":"2011","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B43","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-017-1679-9","article-title":"Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration","author":"Lee","year":"2017","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B44","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2990.2010.01136.x","article-title":"TDP-43 pathology occurs infrequently in multiple system atrophy","volume":"37","author":"Geser","year":"2011","journal-title":"Neuropathol Appl Neurobiol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B45","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/mds.26809","article-title":"Distribution and characteristics of transactive response DNA binding protein 43\u2009kDa pathology in progressive supranuclear palsy","volume":"32","author":"Koga","year":"2017","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B46","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/archneurol.2010.254","article-title":"Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness","volume":"67","author":"Geser","year":"2010","journal-title":"Arch Neurol"},{"key":"key\n\t\t\t\t20180328174221_nlx049-B47","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1146\/annurev-cellbio-100814-125438","article-title":"Mechanism and regulation of cytoplasmic dynein","volume":"31","author":"Cianfrocco","year":"2015","journal-title":"Annu Rev Cell Dev Biol"}],"container-title":["Journal of Neuropathology & Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnen\/article-pdf\/76\/8\/676\/24369010\/nlx049.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T02:57:05Z","timestamp":1522292225000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnen\/article\/76\/8\/676\/3966745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,14]]},"references-count":47,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,7,14]]},"published-print":{"date-parts":[[2017,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnen\/nlx049","relation":{},"ISSN":["0022-3069","1554-6578"],"issn-type":[{"value":"0022-3069","type":"print"},{"value":"1554-6578","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,8]]},"published":{"date-parts":[[2017,7,14]]}}}